VanEck Associates’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.67M Sell
139,059
-24,991
-15% -$1.09M 0.01% 716
2025
Q4
$6.34M Sell
164,050
-12,570
-7% -$479K 0.01% 715
2025
Q3
$6.23M Sell
176,620
-19,904
-10% -$721K 0.01% 689
2025
Q2
$7.08M Buy
196,524
+72,499
+58% +$2.4M 0.01% 593
2025
Q1
$3.86M Sell
124,025
-3,115
-2% -$98.7K 0.01% 810
2024
Q4
$3.24M Buy
127,140
+25,640
+25% +$680K ﹤0.01% 843
2024
Q3
$2.78M Buy
101,500
+64,057
+171% +$1.77M ﹤0.01% 842
2024
Q2
$988K Buy
37,443
+1,980
+6% +$54.9K ﹤0.01% 995
2024
Q1
$1.08M Buy
35,463
+28,987
+448% +$855K ﹤0.01% 974
2023
Q4
$182K Buy
6,476
+2,944
+83% +$80.9K ﹤0.01% 1176
2023
Q3
$96K Buy
3,532
+309
+10% +$9.18K ﹤0.01% 1233
2023
Q2
$99K Buy
+3,223
New +$109K ﹤0.01% 1244

Other funds holding RPRX